*Update – With overwhelming interest, and now almost 70 speakers, including Dennis McKenna, we are pleased to announce the conference will now run on a second day, the 15th of April to allow attendees to make the most of the many panels we will be running. Further details of the extended lineup will be posted shortly.*
In the midst of a global health crisis, Microdose and The Conscious Fund are hosting a worldwide virtual conference for the emerging psychedelic medicine industry, the biggest global event in the space to date. Given the mental health and wellbeing challenges facing the world, the conference is a timely look at the new treatments and therapies which have astonished researchers.
In partnership with The Green Light and The Conscious Fund, a venture capital fund with active investments in the psychedelics industry, this groundbreaking event will bring together CEOs, investors, scientists, researchers, and regulators for an array of panel discussions and collaborative networking.
Psychedelic drugs are showing incredible promise in their ability to treat a vast range of mental health conditions, including addiction, treatment-resistant depression, PTSD, eating disorders, and many more. Forward thinking scientists, a new breed of psychedelic medicine companies and healthcare advocates are learning to harness the power of psychedelics to tackle the worldwide need for mental wellbeing head-on.
Using new virtual conferencing software, attendees will have access to leading psychedelic experts, and discover the latest trends, while building bridges with thought-leaders and exploring unique investment opportunities.
The conference agenda includes a briefing to set the scene on the psychedelics industry, followed by discussions on psychedelic medicine, drug development, regulation, ethics, investment and much more. One to one and group discussions will take place throughout the event.